Elanco Animal Health Inc. (NYSE: ELAN) is a global animal health company offering products for both livestock and companion animals, including vaccines, antibiotics, and parasiticides. Spun off from Eli Lilly, Elanco has expanded its portfolio through the acquisition of Bayer’s animal health business. With growing demand for pet health and food safety, Elanco provides investors with defensive exposure to veterinary pharmaceuticals and agriculture-linked productivity trends.
Últimos artículos sobre acciones